The effect of nutritional support on nutritional status, quality of life, and survival in cancer patients receiving systemic anticancer therapy

Cover Page

Cite item

Full Text

Abstract

Malnutrition, a common problem among cancer patients, due to the direct influence of the tumor and the consequences of specific therapy, negatively affects the patient’s quality of life and is detrimental to the results of anticancer treatment. Nutritional support plays a vital role in systemic drug anticancer therapy; however, malnutrition that develops against a background of malignant neoplasms remains underestimated and receives little attention in clinical practice.

To assess the need for and safety of nutritional support in this context, an analysis of publications in the medical databases e-Library, PubMed, and Medline was performed with an emphasis on assessing the safety and efficacy of NP in the presence of systemic drug antitumor treatment for the period 2003–2022 using the keywords oncology, chemotherapy, nutritional support, omega-3 fatty acids, and glutamine.

The obtained data show that patients with cancer have anorexia-cachexia syndrome, leading to the development of sarcopenia, which negatively affects the results of specific therapy. Timely appointment of nutritional support significantly improves the results of treatment, as well as quality of life, and increases the survival rate in patients receiving non-surgical anticancer therapy; moreover, nutritional support administered in parallel with anticancer drug therapy improves treatment results.

About the authors

Olga A. Obukhova

N.N. Blokhin National Medical Research Center of Oncology

Author for correspondence.
Email: obukhova0404@yandex.ru
ORCID iD: 0000-0003-0197-7721
SPIN-code: 6876-7701

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Ildar A. Kurmukov

N.N. Blokhin National Medical Research Center of Oncology

Email: kurmukovia@gmail.com
ORCID iD: 0000-0001-8463-2600
SPIN-code: 3692-5202

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Alla A. Ryk

N.V. Sklifosovsky Research Institute of Emergency Medicine

Email: alla-ryk@yandex.ru
ORCID iD: 0000-0002-3968-3713
SPIN-code: 3984-7800

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

References

  1. Molfino A, Gioia G, Fanelli RF, Laviano A. Contribution of neuroinflammation to the pathogenesis of cancer cachexia. Mediators Inflamm. 2015;2015:801685. doi: 10.1155/2015/801685
  2. Ni J, Zhang L. Cancer cachexia: definition, staging, and emerging treatments. Cancer Manag Res. 2020;12:5597–5605. doi: 10.2147/CMAR.S261585
  3. Cederholm T, Jensen G, Correia MI, et al. GLIM criteria for the diagnosis of malnutrition ― A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019; 10(1):207–217. doi: 10.1002/jcsm.12383
  4. Obukhova OA, Kurmukov IA, Kashiya SR. Diagnosis and treatment of iron deficiency anemia in oncology. Oncogynecology. 2014;(2):67–76. (In Russ).
  5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi: 10.1093/ageing/afq034
  6. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601. doi: 10.1093/ageing/afz046
  7. Obukhova OA, Bagrova SG, Besova NS, et al. Evaluation of the nutritional status of patients with inoperable gastric cancer at the time of initiation of anticancer treatment. Preliminary results of a prospective observational study. Difficult Patient. 2018;16(6):6–11. (In Russ).
  8. Shachar SS, Deal AM, Weinberg M, et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res. 2017;23(3):658–665. doi: 10.1158/1078-0432.CCR-16-0940
  9. Sealy MJ, Dechaphunkul T, van der Schans CP, et al. Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer. Clin Nutr. 2020;39(2):501–509. doi: 10.1016/j.clnu.2019.02.029
  10. Langius JA, Bakker S, Rietveld DH, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013;109(5):1093–1099. doi: 10.1038/bjc.2013.458
  11. Findlay M, White K, Stapleton N, Bauer J. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis. Clin Nutr. 2021;40(4):1711–1718. doi: 10.1016/j.clnu.2020.09.017
  12. Sytov AV, Leiderman IN, Lomidze SV, et al. Practical recommendations on nutritional support for cancer patients. Practical recommendations of RUSSCO. Malignant Tumors. 2019;9(3s2): 639–647. (In Russ). doi: 10.18027/2224-5057-2019-9-3s2-639-647
  13. Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5): 2898–2913. doi: 10.1016/j.clnu.2021.02.005
  14. Van der Werf A, Langius JA, Beeker A, et al. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin Nutr. 2020;39(10):3005–3013. doi: 10.1016/j.clnu.2020.01.009
  15. Obukhova OA, Snegovoy AV, Kurmukov IA, et al. The nutritional status of oncological patient prior to antitumor treatment: single-center prospective observational study. Clinical Nutrition Metabolism. 2020;1(4):178–189. (In Russ). doi: 10.17816/clinutr64707
  16. Khoronenko V, Sergienko AD, Mandryka EA, et al. Assessment of nutritional status in cancer patients. Difficult Patient. 2018;16(5): 22–26. (In Russ).
  17. Sánchez-Lara K, Turcott JG, Juárez-Hernández E, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr. 2014;33(6):1017–1023. doi: 10.1016/j.clnu.2014.03.006
  18. Dechaphunkul T, Arundon T, Raungkhajon P, et al. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: a phase II randomized, double-blind study. Clin Nutr. 2022;41(2):433–440. doi: 10.1016/j.clnu.2021.12.035
  19. Obukhova OA, Bagrova SG, Besova NS, et al. The influence of additional enteral nutrition with a high content of protein and ω-3 fatty acids on the nutritional status and functional state during chemotherapy in patients with gastric cancer. Nutrition Issues. 2018;87(S5):106–107. (In Russ). doi: 10.24411/0042-8833-2018-10200
  20. Li T, Lv J, Zhu G, et al. Enteral nutrition to improve nutritional status, treatment tolerance, and outcomes in patients with esophageal cancer undergoing concurrent chemoradiotherapy (CCRT): results of a prospective, randomized, controlled, multicenter trial (NCT 02399306). J Clin Oncol. 2017;35(15 Suppl.):4033–4033. doi: 10.1200/JCO.2017.35.15_SUPPL.4033
  21. Belyaeva LE, Pavlyukevich AN. Early programming of human diseases and preventive use of nutraceuticals: focus on fish oils. Literature review. Part 2. Bulletin of Vitebsk State Medical University. 2019;18(5):12–25. doi: 10.22263/2312-4156.2019.5.12
  22. Kreymann KG, Heyland DK, de Heer G, Elke G. Intravenous fish oil in critically ill and surgical patients ― historical remarks and critical appraisal. Clin Nutr. 2018;37(3):1075–1081. doi: 10.1016/j.clnu.2017.07.006
  23. Fietkau R, Lewitzki V, Kuhnt T, et al. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer. 2013;119(18):3343–3353. doi: 10.1002/cncr.28197
  24. Sánchez-Lara K, Turcott JG, Juárez-Hernández E, et al. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial. Clin Nutr. 2014;33(6):1017–1023. doi: 10.1016/j.clnu.2014.03.006
  25. Anderson PM, Lalla RV. Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy. Nutrients. 2020;12(6):1675. doi: 10.3390/nu12061675
  26. Piccirillo N, De Matteis S, Laurenti L, et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica. 2003;88(2):192–200.
  27. Lalla RV, Bowen J, Barasch A, et al. Mucositis guidelines leadership group of the multinational association of supportive care in cancer and international society of oral oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10): 1453–1461. doi: 10.1002/cncr.28592
  28. Chattopadhyay S, Saha A, Azam M. Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: a prospective randomized study. South Asian J Cancer. 2014;3(1): 8–12. doi: 10.4103/2278-330X.126501
  29. Tsujimoto T, Yamamoto Y, Wasa M, et al. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep. 2015;33(1):33–39. doi: 10.3892/or.2014.3564
  30. Peterson DE, Jones JB, Petit RG. Randomized, placebo-controlled trial of saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer. 2007;109(2):322–331. doi: 10.1002/cncr.22384
  31. Peng T, Lin H, Yang L, Wu T. Effectiveness of glutamine in the management of oral mucositis in cancer patients: a meta-analysis of randomized controlled trials. Support Care Cancer. 2021;29(8): 4885–4892. doi: 10.1007/s00520-021-06060-9

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Figure. Synthesis of eicosanoids from fatty acids.

Download (204KB)
Indexing metadata

Copyright (c) 2022 Obukhova O.A., Kurmukov I.A., Ryk A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies